# YAG Laser Vitreolysis for Vitreous Floaters

> **NCT06915922** · NA · RECRUITING · sponsor: **VMR Consulting, Inc.** · enrollment: 50 (estimated)

## Conditions studied

- Posterior Vitreous Detachment
- Myopic Vitreopathy
- VISION DEGRADING MYODESOPSIA

## Interventions

- **DEVICE:** Neodymium-doped yttrium-aluminum-garnet (Nd:YAG) laser therapy

## Key facts

- **NCT ID:** NCT06915922
- **Lead sponsor:** VMR Consulting, Inc.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-17
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06915922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06915922, "YAG Laser Vitreolysis for Vitreous Floaters". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06915922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*